Regeneron to Participate in Guggenheim Biopharma Strategy Series

TARRYTOWN, N.Y. , June 22, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ:   REGN) is scheduled to participate in a virtual fireside chat at the Guggenheim Biopharma Strategy Series – Biopharma’s Next Decade: Views from the Top on Global Strategy and Innovation – at 10:00 a.m.

close

Get every new post delivered right to your inbox.

Original Source